Neema Ngugi: Understanding the D-Dimer Test – A Key Tool in Detecting Blood Clots
Neema Ngugi, Nephrology Nurse Nephrology at The Nairobi South Hospital, shared a post on LinkedIn:
“Understanding the D-Dimer Test: A Key Tool in Detecting Blood Clots
The D-Dimer test plays a crucial role in clinical decision-making, especially when evaluating patients for suspected thrombotic events.
It measures fibrin degradation products – essentially fragments produced when a blood clot dissolves in the body.
Why is it done?
Primarily, the D-Dimer test is used to rule out serious clotting conditions such as:
- Deep Vein Thrombosis (DVT)
- Pulmonary Embolism (PE)
- Disseminated Intravascular Coagulation (DIC)
- Stroke or Myocardial Infarction
How to interpret results?
- Normal D-Dimer – Clotting is unlikely
- Elevated D-Dimer – Not diagnostic, but signals the need for further investigation (e.g., imaging studies)
Important to remember:
An elevated D-Dimer is not specific.
Levels can also rise in conditions such as:
- Infection
- Pregnancy
- Recent surgery
- Liver disease
- Cancer
Clinical takeaway:
The D-Dimer test is most powerful when used appropriately – especially in low to moderate-risk patients – to safely exclude life-threatening clotting conditions and avoid unnecessary imaging.
As healthcare professionals, understanding when and how to use this test ensures accurate diagnosis, timely intervention, and improved patient outcomes.”
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn RuksakulpiwatÖ‰ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin